“…The net decrease in plasma glycine following benzoate administration may be influenced not only by uptake by the liver but also by other factors such as plasma volume, and by the rate of replacement of plasma glycine by tissue stores of the amino acid, In this respect it is noteworthy that the subject of Experiment 9 had an exceptionally low body weight and, accordingly probably a low plasma volume. Furthermore, an intravenous glycine tolerance test on this subject (reported elsewhere [15]) indicated a slow equilibration of plasma glycine with the tissues. It should be pointed out, however, that because of the low body weight 6 gms.…”